Scientific Event

International ME/CFS Conference 2025 Header

Scientific conference under the stewardship of Prof Carmen Scheibenbogen, centred on the care, research, and treatment of ME/CFS and post-COVID syndrome. The two-day hybrid event is directed at medical professionals, researchers and interdisciplinary experts in the fields of medicine and biology.


The event will take place at the Harnack House of the Max Planck Society in Berlin and will be streamed live. Videos of the presentations will be made available on our website after the conference.

All presentations will be held in English. Further information on registration (free of charge) and CME credits will follow shortly.

The organisers of the International ME/CFS Conference 2025 are calling for abstracts for scientific poster presentations.

Posters can be submitted until February 28, 2025 via this link.

Conference sessions and confirmed speakers

Introduction

Carmen Scheibenbogen

Prof Carmen Scheibenbogen, MD

Charité University Medicine Berlin, Germany
Prof David Putrino, PhD

Prof David Putrino, PhD

Icahn School of Medicine at Mount Sinai, New York, USA

Care for ME/CFS

Kathryn Hoffmann

Prof Kathryn Hoffmann, MD, MPH

Medical University of Vienna, Austria
Fridbjörn Sigurdsson
Dr Fridbjörn Sigurdsson, MD
Landspitali – University Hospital, Reykjavik, Iceland
Michael Stingl
Dr Michael Stingl, MD
Facharztzentrum Votivpark, Vienna, Austria
Kristian Sommerfelt
Prof Kristian Sommerfelt, MD
University of Bergen, Norway
Claudia Kedor
Dr Claudia Kedor, MD
Charité University Medicine Berlin, Germany

Understanding I: Cardiovascular dysregulation and mitochondrial pathology

David Systrom
Prof David Systrom, MD
Brigham and Women’s Hospital, Boston, USA
Rob Wüst

Prof Rob Wust, PhD

Vrije Universiteit Amsterdam, Netherlands

Karl Johan Tronstad
Prof Johan Tronstad, PhD
University of Bergen, Norway
Jürgen Steinacker

Prof Jürgen Steinacker, MD

University Clinic Ulm, Germany
Christian Puta
Prof Christian Puta, PhD
University of Jena, Germany

Understanding II: Immune dysregulation and autoimmunity

Jeroen den Dunnen
Prof Jeroen den Dunnen, PhD
Amsterdam University Medical Center, Netherlands
Birgit Sawitzki
Prof Birgit Sawitzki
Charité University Medicine Berlin, Germany
Takashi Yamamura

Prof Takashi Yamamura, MD, PhD

National Center of Neurology and Psychiatry, Japan

Treatment I: Clinical trials​

Øystein Fluge
Prof Øystein Fluge, MD

University of Bergen, Norway

Olav Mella

Prof Olav Mella, MD, PhD

University of Bergen, Norway

Treatment II: Clinical trials - late breaking results

Michael Peluso
Prof Michael Peluso, MD, MHS
University of California San Francisco, USA

More speakers will be announced soon.

For regular updates, subscribe to our newsletter and follow us on social media.

en_GBEnglish